Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0PV0I
|
|||
| Drug Name |
AKCEA-APO(a)-LRX
|
|||
| Indication | Hyperlipoproteinemia [ICD-11: 5C80; ICD-10: E78.4, E78.5] | Phase 2 | [1] | |
| Company |
Akcea Therapeutics Cambridge, MA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.